Endocrine Disorders and Peripheral Arterial Disease: A Series of Reviews

Curr Vasc Pharmacol. 2023;21(3):147-148. doi: 10.2174/1570161121666230516141319.

Pavel Poredoš^{1

2}, Gerit Holger Schernthaner³, Ales Blinc^{1

2}, Dimitri P Mikhailidis⁴, Pier Luigi Antignani⁵, Panagiotis G Anagnostis⁶, Mojca Jensterle^{7

2}, Katica Bajuk Studen^{8

2}, Miso Šabović^{1

2}, Mateja Kaja Jezovnik⁹

¹ Department of Vascular Diseases, University Medical Centre, Ljubljana, Slovenia.
² Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
³ Department of Medicine 2, Division of Angiology, Medical University of Vienna, Vienna, Austria.
⁴ Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London Medical School, University College London (UCL) and Department of Clinical Biochemistry, Royal Free Hospital Campus (UCL), London, UK.
⁵ Vascular Centre, Nuova Villa Claudia, Rome, Italy.
⁶ Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁷ Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, Ljubljana, Slovenia.
⁸ Department of Nuclear Medicine, University Medical Centre, Ljubljana, Slovenia.
⁹ Department of Advanced Cardiopulmonary Therapies and Transplantation, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

No abstract available

Publication types